Centocor/Five Prime Deal Targets Protein Therapeutics For Osteoarthritis, Pulmonary Fibrosis
This article was originally published in The Pink Sheet Daily
Executive Summary
The research and licensing deal with protein-based biotech Five Prime could give the J&J company a therapy for regenerating cartilage.